Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03699540 · ClinicalTrials.gov registry record · Phase 1
Marijuana Effects on Simulated Driving Performance
A Phase 1 study, sponsored by Shanna Babalonis, PhD.
- Completed
- Registry status
- Phase 1
- Development phase
- 10
- Enrollment target
NCT03699540: Completed Phase 1 study, sponsored by Shanna Babalonis, PhD.
NCT03699540 is a Phase 1 study that has completed, run by Shanna Babalonis, PhD. The registered enrollment target is 10 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (83% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03699540, a Phase 1 study, has completed, sponsored by Shanna Babalonis, PhD.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 10 participants
- Enrollment target
Study Summary
This study will examine the effects of various strains of marijuana on simulated driving performance; the effects of alcohol administration will also be examined to further understand how marijuana-induced driving changes compare to the effects of alcohol. Secondary outcomes will include physiological effects, subjective- and observer-rated outcomes, and psychomotor performance under the various dose conditions.
Primary Outcome
Standard deviation of lane position (SDLP) of the car is the amount of weaving/swerving of the car in and out of the lane. It is a frequent metric for assessing driving ability.
Interventions
- DRUG Alcohol
- DRUG Marijuana
- DRUG placebo alcohol
- DRUG Inactive marijuana
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2019-07-01 |
| Est. Completion | 2023-01-01 |
| Phase | Phase 1 |
What the finished NCT03699540 record still lists
NCT03699540 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (83% lower).
The record links to 0 conditions, and to 4 interventions - of which Alcohol is the first listed.
NCT03699540 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03699540 about?
NCT03699540 is a clinical study titled "Marijuana Effects on Simulated Driving Performance". This study will examine the effects of various strains of marijuana on simulated driving performance; the effects of alcohol administration will also be examined to further understand how marijuana-induced driving changes compare to the effects of alcohol. Secondary outcomes will include physiologic...
What is the current status of trial NCT03699540?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 10 participants. The study started on 2019-07-01. Estimated completion is 2023-01-01.
What interventions are being tested in trial NCT03699540?
The interventions under investigation include: Alcohol (DRUG), Marijuana (DRUG), placebo alcohol (DRUG), Inactive marijuana (DRUG).
Who is sponsoring clinical trial NCT03699540?
This trial is sponsored by Shanna Babalonis, PhD, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03699540's enrollment target sits among peer trials
10 1913th of 2000 higher than 46 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI